Anaphylaxis from yellow fever vaccine

被引:83
作者
Kelso, JM
Mootrey, GT
Tsai, TF
机构
[1] USN, Med Ctr, Dept Internal Med, Div Allergy, San Diego, CA 92134 USA
[2] Ctr Dis Control & Prevent, Natl Immunizat Program, Vaccine Safety & Dev Act, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA
关键词
allergy; anaphylaxis; yellow fever vaccine;
D O I
10.1016/S0091-6749(99)70245-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: There are very few reports of anaphylactic reactions to yellow fever (YF) vaccine in the literature, and these date from the 1940s, Objective: We sought to estimate the rate of YF vaccine-related anaphylaxis, Methods: All reports of adverse reactions to YF vaccine submitted to the Vaccine Adverse Event Reporting System between 1990 and 1997 were reviewed for those meeting criteria for probable or possible anaphylactic reactions. Results: Of 243 reports submitted, 40 describe probable or possible anaphylactic reactions. In 22 of these 40, YF vaccine was the only vaccine administered. There were 5,236,820 doses of YF vaccine distributed in the United States during this period. By using all 40 Eases, the rate of YF vaccine-related anaphylaxis would be 40 in 5,236,820 or about 1 in 131,000, In 35 of the reports, information was provided on whether previous doses of YF vaccine had been given. In 34 of these 35, the reaction occurred after the first dose of YF vaccine, suggesting that vaccine constituents other than the viral proteins may have been the allergens. The vaccine is grown in chicken embryos and contains gelatin as a stabilizer. Conclusion: YP vaccine can cause anaphylactic reactions. Persons presenting for YF vaccine should be asked if they have had adverse reactions to previous doses of this or other vaccines and if they are allergic to eggs, chicken, or gelatin. Health care workers administering YF vaccine should be prepared to recognize and treat anaphylactic reactions should they occur.
引用
收藏
页码:698 / 701
页数:4
相关论文
共 18 条
[1]  
*AM COLL PHYS, 1994, GUID AD IMM, P140
[2]   THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS) [J].
CHEN, RT ;
RASTOGI, SC ;
MULLEN, JR ;
HAYES, SW ;
COCHI, SL ;
DONLON, JA ;
WASSILAK, SG .
VACCINE, 1994, 12 (06) :542-550
[3]  
*CONN LAB INC, 1986, PACK INS YF VAX YELL
[4]   STABILIZED 17D STRAIN YELLOW-FEVER VACCINE - DOSE-RESPONSE STUDIES, CLINICAL REACTIONS AND EFFECTS ON HEPATIC FUNCTION [J].
FREESTONE, DS ;
FERRIS, RD ;
WEINBERG, AL ;
KELLY, A .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1977, 5 (03) :181-186
[5]   ALLERGIC REACTIONS TO MEASLES (RUBEOLA) VACCINE IN PATIENTS HYPERSENSITIVE TO EGG PROTEIN [J].
HERMAN, JJ ;
RADIN, R ;
SCHNEIDERMAN, R .
JOURNAL OF PEDIATRICS, 1983, 102 (02) :196-199
[6]   SAFE ADMINISTRATION OF THE MEASLES-VACCINE TO CHILDREN ALLERGIC TO EGGS [J].
JAMES, JM ;
BURKS, AW ;
ROBERSON, PK ;
SAMPSON, HA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19) :1262-1266
[7]   ANAPHYLAXIS TO MEASLES, MUMPS, AND RUBELLA VACCINE MEDIATED BY IGE TO GELATIN [J].
KELSO, JM ;
JONES, RT ;
YUNGINGER, JW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (04) :867-872
[8]  
MONATH TP, IN PRESS VACCINES
[9]   YELLOW-FEVER VACCINE AND EGG ALLERGY [J].
MOSIMANN, B ;
STOLL, B ;
FRANCILLON, C ;
PECOUD, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (05) :1064-1064
[10]   A CLINICAL-STUDY OF STABILIZED 17D STRAIN LIVE ATTENUATED YELLOW-FEVER VACCINE [J].
MOSSBLUNDELL, AJ ;
BERNSTEIN, S ;
SHEPHERD, WM ;
LANGFORD, DT ;
FERRIS, R ;
KELLY, A .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1981, 9 (04) :445-452